Exagen Inc. (XGN) Tops Q3 EPS by 16c

Exagen Inc. (NASDAQ: XGN) reported Q3 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $10.33 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• JPMorgan cuts 2026 box office forecast on slow third quarter
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance